Top-News
Sonstige private Dienstleistungen USA

Marker Therapeutics News

Aktie
WKN:  A3D5YK ISIN:  US57055L2060 US-Symbol:  MRKR
4,23 $
-0,54 $
-11,32%
03.05.24 19:22:29
Handeln Depot/Watchlist
Aktienanzahl *
8,36 Mio.
Marktkapitalisierung *
32,08 Mio. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 30.01.2023

Marker Therapeutics News

05.08.22 - PR Newswire
Thinking about buying stock in Marker Therapeutics, Helius Medical Technologies, T2 Biosystems, Missfresh, or LYFT?
Thinking about buying stock in Marker Therapeutics, Helius Medical Technologies, T2 Biosystems, Missfresh, or LYFT? PR Newswire
09.12.21 - PR Newswire
Marker Therapeutics Appoints Biotech Executive Katharine Knobil, M.D., to Board of Directors
Marker Therapeutics Appoints Biotech Executive Katharine Knobil, M.D., to Board of Directors PR Newswire
18.11.21 - PR Newswire
Marker Therapeutics Announces that Data from Investigator-Sponsored Phase 1 Study With its MultiTAA-Specific T Cells to be Presented at the 2021 American Society of Hematology Annual Meeting
Marker Therapeutics Announces that Data from Investigator-​Sponsored Phase 1 Study With its MultiTAA-​Specific T Cells to be Presented at the 2021 American Society of ...
10.11.21 - PR Newswire
Marker Therapeutics Reports Third Quarter 2021 Operating and Financial Results
Marker Therapeutics Reports Third Quarter 2021 Operating and Financial Results Enrollment of first 20 patients of the Company's Phase 2 AML trial anticipated in Q4 2021 Topline ...
07.09.21 - PR Newswire
Marker Therapeutics to Present at Three Upcoming September Investor Conferences
Marker Therapeutics to Present at Three Upcoming September Investor Conferences PR Newswire
20.08.21 - PR Newswire
Thinking about buying stock in Geovax Labs, Marker Therapeutics, Agile Therapeutics, FibroGen, or Pixelworks?
Thinking about buying stock in Geovax Labs, Marker Therapeutics, Agile Therapeutics, FibroGen, or Pixelworks? PR Newswire
19.08.21 - PR Newswire
Marker Therapeutics Awarded $13.1 Million Grant from the Cancer Prevention and Research Institute of Texas
Marker Therapeutics Awarded $13.1 Million Grant from the Cancer Prevention and Research Institute of Texas PR Newswire
10.08.21 - PR Newswire
Marker Therapeutics Reports Second Quarter 2021 Operating and Financial Results
Marker Therapeutics Reports Second Quarter 2021 Operating and Financial Results Marker continues to enroll patients and activate clinical sites in Phase 2 AML trial following ...
28.07.21 - PR Newswire
Marker Therapeutics Announces Opening of New cGMP Manufacturing Facility
Marker Therapeutics Announces Opening of New cGMP Manufacturing Facility Facility is now available to manufacture study drug, MT-401, for Marker's Phase 2 AML trial PR Newswire
06.07.21 - PR Newswire
Marker Therapeutics Announces Completion of Safety Lead-In Portion of Phase 2 Study in Post-Transplant AML
Marker Therapeutics Announces Completion of Safety Lead-In Portion of Phase 2 Study in Post-​Transplant AML Company continues to enroll patients in main portion of the Phase 2 ...
16.06.21 - PR Newswire
Marker Therapeutics to Present at the Virtual Raymond James Human Health Innovation Conference
Marker Therapeutics to Present at the Virtual Raymond James Human Health Innovation Conference PR Newswire
12.05.21 - PR Newswire
Marker Therapeutics Reports First Quarter 2021 Operating and Financial Results
Marker Therapeutics Reports First Quarter 2021 Operating and Financial Results Marker continues to advance Phase 2 AML trial, recently dosing first patient Company closed ...
29.04.21 - PR Newswire
Marker Therapeutics to Host First Quarter 2021 Operating and Financial Results Conference Call and Webcast on Wednesday, May 12, 2021
Marker Therapeutics to Host First Quarter 2021 Operating and Financial Results Conference Call and Webcast on Wednesday, May 12, 2021 PR Newswire
29.04.21 - PR Newswire
Thinking about buying stock in Hall of Fame Resort & Entertainment, Marker Therapeutics, LendingClub, Smith & Nephew, or Clover Health Investments?
Thinking about buying stock in Hall of Fame Resort & Entertainment, Marker Therapeutics, LendingClub, Smith & Nephew, or Clover Health Investments? PR Newswire
27.04.21 - PR Newswire
Marker Therapeutics to Present Multi-Tumor-Associated Antigen (mTAA)-Specific T Cell Manufacturing Robotics Data at the 2021 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
Marker Therapeutics to Present Multi-​Tumor-Associated Antigen (mTAA)-Specific T Cell Manufacturing Robotics Data at the 2021 American Society of Gene & Cell Therapy (ASGCT) ...
22.03.21 - PR Newswire
Thinking about buying stock in Acer Therapeutics, Cemtrex, Comstock Mining, Marker Therapeutics, or Strongbridge Biopharma?
Thinking about buying stock in Acer Therapeutics, Cemtrex, Comstock Mining, Marker Therapeutics, or Strongbridge Biopharma? PR Newswire
19.03.21 - PR Newswire
Thinking about buying stock in SenesTech, Marker Therapeutics, Strongbridge Biopharma, Kiniksa Pharmaceuticals, or Rockwell Medical?
Thinking about buying stock in SenesTech, Marker Therapeutics, Strongbridge Biopharma, Kiniksa Pharmaceuticals, or Rockwell Medical? PR Newswire
16.03.21 - PR Newswire
Marker Therapeutics, Inc. Announces Closing of Public Offering of Common Stock
Marker Therapeutics, Inc. Announces Closing of Public Offering of Common Stock PR Newswire
15.03.21 - PR Newswire
Marker Therapeutics to Present at the Virtual Oppenheimer 31st Annual Healthcare Conference
Marker Therapeutics to Present at the Virtual Oppenheimer 31st Annual Healthcare Conference PR Newswire
11.03.21 - PR Newswire
Marker Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
Marker Therapeutics, Inc. Announces Proposed Public Offering of Common Stock PR Newswire

Newssuche

Videos

newspaper
03.05.24 -13,45%
Technical Trading: Gold freitags Long
Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »